Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novartis Opts For OTC Recall, With J&J/McNeil Lessons Still Fresh

This article was originally published in The Tan Sheet

Executive Summary

After shuttering its Lincoln, Neb., OTC facility, the firm recalls some lots of Bufferin, Excedrin, Gas-X and NoDoz. FDA found a “pattern of problems” when inspecting the plant in 2011, and Novartis’ actions suggest it seeks to avoid the same scrutiny that Johnson & Johnson’s OTC recalls elicited.

Advertisement

Related Content

Liquid Rolaids Featured In Line’s Re-launch Into Crowded Antacid Market
Liquid Rolaids Featured In Line’s Re-launch Into Crowded Antacid Market
Bayer Migraine Formula Seeks Market Share Before Excedrin Returns
Bayer Migraine Formula Seeks Market Share Before Excedrin Returns
Perrigo Launch Investments Hold Income Back, As Firm Girds For 2013
In Brief
Perrigo Applies Crime Scene Investigation Model To Improve Quality Control
Perrigo To Launch Private Label Mucinex, Prevacid, With An Eye On Lipitor
J&J/McNeil Done With Post-Recall Personnel Changes - CEO Weldon
McNeil Expands Tylenol Recall As FDA Criticizes Firm's Response To AERs

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS105510

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel